CANCER NOMENKLATURE AND SUSTAINED PROLIFERATIVE SIGNALING

dc.contributor.authorRaxmonov Shoxzodbek Oybek o’g’li
dc.date.accessioned2025-12-29T17:57:40Z
dc.date.issued2025-02-25
dc.description.abstractCancer is a leading cause of suffering and death in the developed world. It is now understood that cancer is a collection of more than 100 different diseases, each caused by a specific and often unique age-related accumulation of genetic and epigenetic alterations. Environment, heredity, and behavior interact to modify the risk of developing cancer and the response to treatment. Improvements in treatment strategies and supportive care, coupled with new, often individualized therapies based on advances of the basic pathophysiology of malignancy, have contributed to an increasing number of effective options for these diverse, often lethal disorders collectively called cancer.
dc.formatapplication/pdf
dc.identifier.urihttps://webofjournals.com/index.php/5/article/view/3397
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/24435
dc.language.isoeng
dc.publisherWeb of Journals Publishing
dc.relationhttps://webofjournals.com/index.php/5/article/view/3397/3355
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWeb of Medicine: Journal of Medicine, Practice and Nursing ; Vol. 3 No. 2 (2025): WOM; 413-417
dc.source2938-3765
dc.subjectCancer, rhabdomyosarcoma, guanine diphosphate (GDP), epidermal growth factor (EGF), guanine triphosphate (GTP).
dc.titleCANCER NOMENKLATURE AND SUSTAINED PROLIFERATIVE SIGNALING
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
ogli_2025_cancer_nomenklature_and_sustained_prolif.pdf
item.page.filesection.size
281.59 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections